GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

LUNG · Mar 31, 2024

Pulmonx Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001127537-24-000052General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

197.48% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.39% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-62.56% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

91.38% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

74.67% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

-77.10% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

22.33% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

30.09% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20258/9 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
54.23%
Current
197.48%
Delta
143.25%
Capex Intensity Increased
Previous
1.18%
Current
2.39%
Delta
1.22%
Cash Generation Decreased
Previous
-54.77%
Current
-62.56%
Delta
-7.79%
Inventory Pressure Increased
Previous
24.38%
Current
91.38%
Delta
67.00%
Margin Increased
Previous
73.90%
Current
74.67%
Delta
0.77%
Profitability Increased
Previous
-90.19%
Current
-77.10%
Delta
13.09%
R And D Intensity Decreased
Previous
26.33%
Current
22.33%
Delta
-4.00%
Sbc Intensity Decreased
Previous
32.18%
Current
30.09%
Delta
-2.09%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · LUNG Fundamental State →Transitioned To · LUNG Fundamental State →Transitioned To · LUNG BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · LUNG CAPEX_INTENSITY_INCREASED →Transitioned To · LUNG CASH_GENERATION_DECREASED →Transitioned To · LUNG INVENTORY_PRESSURE_INCREASED →Transitioned To · LUNG MARGIN_INCREASED →Transitioned To · LUNG PROFITABILITY_INCREASED →Transitioned To · LUNG R_AND_D_INTENSITY_DECREASED →Transitioned To · LUNG SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.